Vaginal neoplasm
Therapeutic area
Reproductive Health
Rare disease
No
- Definition
- A benign or malignant neoplasm affecting the vagina. Representative examples of benign neoplasms include squamous papilloma and melanocytic nevus. Representative examples of malignant neoplasms include carcinoma, melanoma, and sarcoma.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Vaginal neoplasm
- Therapeutic area
- Reproductive Health
- vaginal neoplasm
- neoplasm of the vagina
- neoplasm of vagina
- tumor of the vagina
- tumor of vagina
- tumour of the vagina
- tumour of vagina
- vagina neoplasm
- vagina neoplasm (disease)
- vagina tumor
- vagina tumour
- vaginal neoplasm
- vaginal tumor
- vaginal tumour
- Severity
- Unknown
- Oncology
- Reproductive Health
- MONDO ID
- MONDO:0021050
- Parent condition
- MONDO:0001433
Related records
Broader conditions (12)
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Female reproductive system disorder
- Female reproductive system neoplasm
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
- Reproductive system disorder
- Reproductive system neoplasm
- Vaginal disorder
Narrower conditions (31)
- Adult vagina botryoid embryonal rhabdomyosarcoma
- Benign vaginal mixed epithelial and mesenchymal neoplasm
- Benign vaginal mixed tumor
- Benign vaginal neoplasm
- Botryoid-type embryonal rhabdomyosarcoma of the vagina
- Childhood vagina botryoid rhabdomyosarcoma
- Endometrioid stromal and related neoplasms of the vagina
- Endometrioid stromal sarcoma of the vagina
- Extraovarian Brenner tumor of the vagina
- Malignant vaginal mixed epithelial and mesenchymal neoplasm
- Vagina leiomyosarcoma
- Vagina sarcoma
- Vaginal adenocarcinoma
- Vaginal adenoid cystic carcinoma
- Vaginal adenoma
- Vaginal adenosarcoma
- Vaginal cancer
- Vaginal carcinoma
- Vaginal carcinosarcoma
- Vaginal germ cell malignant tumor
Trials (155)
- 3D Printed Custom Applicators for HDR BT (DISCO)
- A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
- A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
- A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
- A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
- A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
- A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
- A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer
- A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
- A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)
- A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)
- A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
- A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
- A Survivorship Care Plan for Gynaecological Cancer Patients
- A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
- Agnostic Therapy in Rare Solid Tumors
- Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
- ASk Questions in GYnecologic Oncology (ASQ-GYO)
- Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study
- Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin